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NO was reported to activate guanylate cyclase and, recently, prostaglandin H synthase. NO interaction with the heme component in different 
hemeproteins i determined by ligand property, electronic ontiguration of the heme iron and the specitic effects contributed by the protein structure. 
It is found that although NO interaction with the free heme provides some common rules of interaction, the consequences ofNO binding to different 
hemeproteins hould be dealt with individually. 
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1. Introduction 
Nitric oxide (NO), Science magazine’s compound of 
the year for 1992, has been shown to be involved in many 
important biological functions. It serves as a neurotrans- 
mitter, a vasodilator, a strong inhibitor of platelet aggre- 
gation. It is also involved in the bacteria-killing process 
by macrophages. The issue of whether NO is a ‘good’ or 
‘bad’ molecule is currently under extensive investigation 
[l], and guanylate cyclase is generally accepted to be the 
principal target of NO action [2]. Guanylate cyclase is a 
hemeprotein and its activity was found to increase by 
two orders of magnitude in the presence of NO [3]. The 
concept that NO activates guanylate cyclase via direct 
interaction with the heme moiety was advanced by two 
groups [2,4], and has been further extended to other 
hemeproteins. One interesting example is the proposal 
that NO activates prostaglandin H synthase [5,6]. This 
kind of hypothesis requires careful evaluation. Is NO 
activation of hemeprotein a general phenomenon? This 
article reviews the basic chemical nature of NO and 
heme, and considers the interaction between NO and free 
heme or heme-containing proteins. 
2. Electronic configuration and the chemical reactivity of 
different gas molecules 
Table 1 presents several isoelectronic diatomic and 
triatomic molecules. Among the series of molecules with 
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10 electrons in the outer shell, CO, but not nitrogen, was 
found to be a strong field ligand for ferrous heme (Table 
2). The molecular orbital theory provides a clear expla- 
nation for this difference (Fig. 1). In the nitrogen mole- 
cule, the three p orbitals are perfectly aligned for bond- 
ing. The bond order is 3, one Q and two K bondings, 
accommodating all six electrons paired in the fully-occu- 
pied bonding orbitals. This electronic configuration 
makes it stable and very inert. Carbon monoxide also has 
a bond order of 3, but the difference of electronegativity 
between the oxygen and carbon atom results in molecu- 
lar orbitals which are quite different from nitrogen (Fig. 
1). The CO orbital with sp hybridization has 4 electrons 
in 2 non-bonding orbitals, with one lone pair producing 
decent reactivity. Though oxygen, with 12 outer-shell 
electrons, appears very symmetrical (based on valence 
bond theory), and is a quite active molecule. Simple anal- 
ysis by an LCAO (linear combination of atomic orbitals) 
method reveals that the two additional electrons (com- 
pared with nitrogen), are located in two antibonding z 
orbitals. These two ‘high energy’ electrons give oxygen 
its reactive attributes and the potential to be a heme 
ligand. For similar reasons, we would expect hat isoelec- 
tronic NO- (Table l), which was recently proposed as 
another physiologically active form of nitric oxide, will 
be an active molecule [7J NO, with 11 electrons in the 
outer shell, is intermediate between oxygen and CO, 
thus the last electron has to be located in a n* orbital. 
The energy difference between this antibonding orbital 
and the o nonbonding orbital in NO is not as well sepa- 
rated as those in CO (Fig. 1). This electronic configura- 
tion results in some unique properties of NO in terms of 
its action as a heme ligand. 
All rights reserved. 
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Fig. 1. Energy diagram of diatomic molecules. Panel A shows the molecular orbital energy diagram of homo-diatomic molecules, nitrogen and oxygen. 
Panel B shows the energy levels of different orbitals in hetero-diatomic molecules, CO and NO. Orbital hybridization and energy promotion of carbon 
(or nitrogen) atom relative to oxygen atom is shown. The unpaired electron included in the circle indicates electron comes from the atom with higher 
atomic number. (Adapted from Huheey, [8]). 
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3. Factors that determine the interaction between free 
heme and the ligands 
A major factor in heme-ligand coordination is the 
redox state of the heme iron. At physiological pH, ferric 
heme has a net unitary positive charge (+3 from Fe3’ and 
-2 from the four pyrrole nitrogens) whereas ferrous 
heme is neutral (+2 from Fe” and -2 from pyrrole nitro- 
gens). Ferric heme therefore tends to react more strongly 
with anionic ligands because of electrostatic interaction. 
The binding strength of the charged ligands follows the 
so-called spectrochemical series [8], cyanide > nitrite, 
azide > hydroxide > halides, and can be ranked simply 
by strength of the Lewis base. In other words, the conju- 
gated base of a strong acid is a weak base, and also a 
weak ligand. On the other hand, ferrous heme preferen- 
tially interacts with neutral gaseous ligands compared to 
ferric heme, and this is due to the increased orbital inter- 
actions. Ferrous heme (d “) has one additional d-orbital 
electron compared to ferric iron (d ‘). This additional 
electron doubles the interaction between the iron d,ldy, 
Table 1 
Isoelectronic diatomic and triatomic molecules 
Molecule 
CO, N,, CN-, NO+ 
NO 
0,, NO- 
N;, COz, N,O 
Outershell electrons 
10 
11 
12 
16 
orbitals and the antibondingp orbital of either the car- 
bon (in CO) or the nitrogen (in NO) (Fig. 2). Such back- 
bonding appears to play an important role in the interac- 
tion between ferrous heme and gaseous ligands. The 
ligand strength with ferrous heme follows the order: NO 
> CO > O2 (Table 2). The fact that CO is a stronger 
ligand than oxygen can be rationalized by the type of 
bonding between the ligand and the heme iron. It has 
been found that the Fe-C-O arrangement is linear with 
ferrous heme, whereas the Fe-O-O arrangement is bent 
[9]. It is clear that CO adopts an sp hybridized orbital and 
O2 uses an sp2 hybridized orbital for heme ligation. We 
thus can expect a stronger bonding and shorter bond 
length between iron-CO than those between iron-oxy- 
gen and this expectation is substantiated by experimental 
observations (Table 2). Furthermore, the presence of two 
electrons in the antibonding orbitals of O2 prohibits the 
backbonding from the iron as compared to CO or NO. 
The remaining question is why NO is a stronger ligand 
than CO? 
4. Unique properties of NO 
Heme coordination by NO exhibits multiple aspects. 
Not only does NO interact strongly with ferrous heme, 
but its odd number of electrons makes NO polar enough 
to be a decent ligand for ferric heme. NO can interact 
with heme using either a sp or a sp2 hybridized orbital, 
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Fig. 2. x bonds between the heme iron d orbital(s) and ligand (A) p 
orbital(s), (B) d orbital(s), and (C) K anti-bonding orbitals. (Adapted 
from Huheey, [8]). 
thus aligning itself either in a linear or bent arrangement. 
In fact, complexes containing both linear and bent ar- 
rangements of NO ligands are not uncommon [8]. NO 
can be, as well as a 2-electron donor, a 3-electron donor. 
This versatility makes it a stronger ligand than CO. The 
3rd unpaired electron can also serve as a reducing equiv- 
alent to convert the iron to the ferrous state after NO 
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binding to ferric heme. Furthermore, the odd electron of 
NO makes this molecule paramagnetic. The unpaired 
electron can interact through the axial ligation with the 
proximal ligand nucleus, such as histidine nitrogen. This 
latter property has been extensively exploited in a stand- 
ard protocol to determine if the proximal heme ligand in 
a hemeprotein is an imidazole [S]. If the proximal site is 
unoccupied or not an imidazole, a 3-line hyperfme EPR 
spectrum is observed as a result of the interaction be- 
tween the unpaired electron of NO and its nitrogen nu- 
cleus (nuclear spin = 1). With a proximal nitrogen ligand, 
a nine-line hyperfine structure is produced, due to the 
interaction of the unpaired electron of NO with two 
nitrogen nuclei [lo]. A 3-electron transfer from NO to the 
heme iron also leads to a repulsive trans effect on any 
proximal heme ligand. In contrast to CO or O2 whose 
binding strength increase with a basic ligand present at 
the 5th position, NO binds more tightly to heme when 
the 5th position is empty [4]. This special characteristic 
has been proposed as a mechanism of guanylate cyclase 
activation by NO [4], which will be discussed further 
below. 
5. Effects of the protein environment on ligand binding by 
heme 
The influences of the protein component on heme- 
ligand interactions can be classified into three general 
categories. 
a. Steric effects: for a given ligand, free heme model 
compounds usually show faster association and dissoci- 
ation rates than found in hemeproteins (Table 2). Asso- 
ciation of a ligand to five-coordinated heme is usually 
faster than to six-coordinated heme because breakage of 
Table 2 
Equilibrium constants and rate constants for NO, CO, 0, binding to model heme compounds and hemeproteins” 
Heme Ligand K (M-l) kr (M-’ . s-‘) k+ (s-7 Reference 
Fe(II)PP( 1 -MeIm) NO 5.8 x 10” 1.8 x 10’ 2.9 x 1o-4 17 
co 7.8 x lo8 1.8 x lo6 2.3 x lo-’ 17 
Fe(II)TPPS NO 1.8 x lo9 -0 18 
Fe(III)TPPS NO 1.1 x 10’ 7.2 x lo5 6.8 x lo2 18 
Mb(B), whale NO 3.4 x 10” 1.7 x 10’ 1.2 x 1o-4 17, 18 
co 4.5 x lo7 5.0 x 105 2.1 x lo+ 17, 19 
2.9 x 10’ 5.5 x lo5 1.9 x lo-2 20 
02 1.9 x lo6 1.9 x 10’ 10 9 
1.1 x lo6 1.6 x 10’ 14 20 
Mb(II), L29F co 3.7 x 10’ 2.2 x lo5 6.0 x lo-’ 20 
02 1.5 x 10’ 2.1 x 10’ 1.4 20 
Mb(III), whale NO 1.4 x lo4 1.9 x lo5 13.6 18 
5.3 x lo4 14 19 
Mb(III), elephant NO 2.2 x 10’ 40 19 
Cyt c(II), horse NO 2.89 x lo5 8.3 2.87 x 1O-5 18 
Cyt c(III), horse NO 1.6 x lo4 7.2 x 10’ 4.4 x lo-* 18 
Cat(III), bovine NO 1.8 x 10’ 3.0 x 10’ 1.7 x ld 18 
“Conditions for the measurements were pH 7.0 and 19-21”C, except pH 9.0 was used for the model compound Fe(II)PP(l-MeIm), and pH 6.5 was 
used for the experiments performed in [17]. 
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a preexisting bond is required to form the new ligation 
(compare cytochrome c with myoglobin in Table 2). As 
a consequence of steric hindrance at the distal side of the 
heme pocket, CO binds to myoglobin heme with a tilted 
rather than in the linear geometry found in heme model 
compounds. Steric hindrance which preventing dissocia- 
tion of bound ligand is well illustrated by the L29F mu- 
tant of myoglobin, in which Leu-29 was replaced by the 
more bulky phenylalanine and resulted in a lo-fold de- 
crease in the dissociation rate constant (Table 2). 
b. Solubility effects: a hydrophilic heme pocket favors 
access of ionic ligands to the heme iron, whereas a heme 
pocket with mainly nonpolar amino acids would facili- 
tate binding of neutral ligands. 
c. Effects of specific amino acid: a good example is the 
hydrogen bonding between the distal heme ligand of 
myoglobin, histidine (E7), which has an adjacent water 
molecule and has a critical influence on the ligand disso- 
ciation rate. 
Examples of a combination of several effects are also 
suggested by the data in Table 2. The rapid association 
of NO to ferric catalase is probably due to both steric 
and solubility effects. In elephant myoglobin, the distal 
histidine (E7) is replaced by a glutamine thereby disrupt- 
ing the hydrogen-bonding with the specific water mole- 
cule. Removal of this steric effect substantially enhances 
the association of the sixth ligand. However, the unusu- 
ally large association rate in this myoglobin (Table 2) is 
likely not to be the consequence of hydrogen bonding 
disruption alone. 
6. Effect of NO on specific bemeproteins 
That NO inhibits the oxygen-carrier function of myog- 
lobin (or hemoglobin) is a classical example of specific 
interaction of NO with hemeprotein. The most recent 
interesting example of a hemeprotein affected by NO is 
probably guanylate cyclase, an enzyme that catalyses the 
conversion of GTP to cyclic GMP and pyrophosphate. 
This hemeprotein has been purified to homogeneity, and 
its optical absorption spectrum is indicative of a 5-coor- 
dinated ferrous heme [I 11. The catalytic activity of 
guanylate cyclase is increased by lo- to lOO-fold in the 
presence of NO or NO-releasing compounds [3]. Based 
on the findings that free protoporphyrin IX gave the 
same activation effect as NO-heme, and that free heme 
inhibits (not activates) the enzyme [12], Ignarro pro- 
posed that a heme structure change is caused by NO 
binding. He suggested that heme, once bound by NO, 
elicits an out-of-plane movement of the center iron, to 
produce a heme core size similar to that of a free porphy- 
rin [2]. This is exactly the opposite of the sequence which 
occurs in the oxygen-myoglobin interaction. 
Sharma and Traylor [13] combined their study of 
model heme systems with Ignarro’s proposal to derive an 
interesting interpretation for the enhancement of enzyme 
activity by NO. Based on the finding that NO binds 
preferentially to the heme lacking a proximal ligand, 
Sharma and Traylor proposed that when NO binds 
heme, there is a tendency to expel the basic ligand on the 
proximal side of the heme. This mechanism liberates a 
free base to catalyze the hydrolysis of the phosphate 
diester bond of GTP. An experiment using NO to release 
the 1-methylimidazole from a 5-coordinated model heme 
did in fact promote hydrolysis ofp-nitrophenolate in the 
aqueous phase [13]. In contrast to Ignarro’s proposal 
using porphyrin as the active component, Sharma and 
Trayler suggested that the basic ligand serves as the crit- 
ical species to cause enzyme activation. However, several 
important aspects of the proposed mechanism remain to 
be examined. It is not known whether heme is present in 
the ferric form in the native enzyme, because reductants 
such as dithiothreitol are used during enzyme purifica- 
tion [3,11]. Further, NO does bind to ferrous heme with 
high strength (Table 2) and also promotes dissociation 
of heme from proteins; both events would tend to se- 
verely limit the number of turnovers and thus make for 
a very inefficient biocatalyst. 
The second interesting current example of NO interac- 
tions with heme proteins is prostaglandin H synthase 
(PGHS). Two groups have proposed that NO interacts 
with the PGHS heme to enhance the cyclooxygenase 
activity [5,6]. Needleman’s group reported that NO or 
NO-releasing compounds stimulated the formation of 
prostaglandin by the two isozymes of PGHS by 2- to 
8-fold [5]. McCann and his colleagues proposed that NO 
diffuses into adjacent neurons to activate PGHS and 
causes the release of PGE,[6], but no experimental evi- 
dence was provided. These proposals of a stimulatory 
effect of NO on PGHS are contradicted by a report of 
Kanner et al. [14] who found reversible inhibition of 
PGHS activity by NO. PGHS has a heme coordination 
very similar to that in myoglobin, with a histidine as the 
proximal axial heme ligand [15]. Studies with purified 
PGHS have indicated that ferric PGHS binds NO very 
weakly (& - mM), whereas ferrous PGHS interacts 
with NO very strongly and leads to release of NO-heme 
free from the proximal ligand, histidine (Tsai et al., un- 
published results). No activation of PGHS activity was 
observed at NO concentrations ranging from micromo- 
lar to mM. It is worth noting that PGHS is a peroxidase 
and that there is no evidence that ferrous heme is in- 
volved in PGHS catalysis. Moreover, it seems quite un- 
likely that the freely diffusible NO could accumulate to 
mM levels in any intracellular compartment. Thus, it 
appears highly improbable that a direct action of NO on 
PGHS heme could be responsible for the reported in- 
crease in prostaglandin synthesis [5]. The possibility of 
other effects of NO on the PGHS protein remain to be 
examined. 
A recent report of the discovery of reversible heme- 
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binding proteins in the salivary gland from a blood- 
sucking insect is very fascinating [16]. Apparently these 
ferric hemeproteins erve as reservoir for NO in the sal- 
ivary gland to prevent the blood coagulation to facilitate 
their blood-feeding routine. It is predicted that these 
hemeproteins hould exhibit NO binding stronger than 
that of PGHS or metmyoglobin. 
In summary, there are general rules to predict the 
reactivity between NO and free heme. Once the heme is 
included inside the protein, not only the axial ligands 
provided by the protein play deciding roles in the NO- 
heme interaction, many additional factors unique for 
each protein have to be considered as well. The coordina- 
tion of NO to the heme moiety of various hemeproteins 
depends on the redox state of the iron, the presence and 
the nature of the axial ligand(s), the heme pocket geom- 
etry and the specific amino acid residues interacting di- 
rectly or indirectly with NO. The effect of NO varies 
from hemeprotein to hemeprotein and can be associated 
with important changes in catalytic function. 
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